Artera partners with Tempus to expand AI cancer test access
American companies Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. The post Artera partners with Tempus to expand AI cancer test access appeared first on Medical Device Network.
American companies Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test.
The post Artera partners with Tempus to expand AI cancer test access appeared first on Medical Device Network.
